Navigation Links
Martek Announces Second Quarter 2008 Financial Results
Date:6/4/2008

Second Quarter Highlights: - Record revenues of $90.7 million, up 18% from the prior year's second

quarter - Earnings per share of $0.28, an increase of approximately 87% over last

year's second quarter - Operating cash flow of $23.6 million (Year-to-date operating cash flow of

$38.8 million) - Launch of eight new food and beverage and four new nutritional supplement

products containing life'sDHA(TM)

COLUMBIA, Md., June 4 /PRNewswire-FirstCall/ -- Martek Biosciences Corporation (Nasdaq: MATK) today announced its financial results for the second quarter of fiscal 2008. Revenues for the second quarter were $90.7 million, up 18% from $76.7 million in the second quarter of fiscal 2007. Net income was $9.2 million, or $0.28 per diluted share, for the second quarter of fiscal 2008 compared with $4.9 million, or $0.15 per diluted share, in last year's second quarter.

Commenting on the quarter, Chief Executive Officer Steve Dubin said, "Martek's strong second quarter results reflect the continued execution of the Company's business plan. Martek's core infant formula business grew, especially overseas, and solid revenue increases were seen in non-infant formula markets. Interest from food, beverage and supplements companies in our nutritional oils continues to grow which should lead to further expansion of our non-infant formula business. In addition, advancements continue in the development of both new applications for life'sDHA(TM) as well as new products to support Martek's long-term growth."

Second Quarter and Year-to-Date Revenue Summary

Product sales in the second quarter
'/>"/>

SOURCE Martek Biosciences Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. Martek to Announce Third Quarter 2007 Results on September 5, 2007
2. Martek to Present at Upcoming UBS Conference
3. Martek Signs Multi-Year Worldwide Sole Source Supply Agreement with Abbott
4. Martek Announces Settlement of OmegaTech Milestone Litigation
5. Martek to Obtain Permanent Injunction Against Lonza in U.S. Patent Infringement Suit; Jury Verdict on Infringement of Two of Three Patents Upheld by Judge
6. European Patent Office Upholds Martek European DHA Food Patent; Scope of Original Claims Narrowed
7. Martek to Present at Upcoming ThinkEquity Partners Conference
8. Martek Announces Fourth Quarter and FY 2007 Financial Results
9. Martek Signs DHA/ARA License and Supply Agreement With IlDong Foodis for Infant Formula in South Korea
10. Leading DHA Expert and Former NIH Researcher, Dr. Norman Salem, Jr., to Join Martek as Chief Scientific Officer
11. Challenge Spreadable Butter Now Features Marteks lifesDHA(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... 2015  Dyadic International, Inc. ("Dyadic") (OTCQX: DYAI), ... technologies are used to develop, manufacture and sell ... chemical, biopharmaceutical and industrial enzyme industries, announced today ... year ending December 31, 2014 after market close ... a conference call that day at 5:00 p.m. ...
(Date:2/26/2015)... , Feb. 26, 2015   Lexicon Pharmaceuticals, Inc. ... will present at the Cowen 35 th Annual Health ... EST in Boston .  Lexicon management will ... A webcast of the presentation will be available ... of the presentation will be available at www.lexpharma.com ...
(Date:2/26/2015)... 26, 2015 Phosphate Therapeutics, ... the first pivotal trial of PT20 in subjects ... disease (DD-CKD), has completed as the pre-specified number ... invented by leading UK-based scientists from the Medical ... is a novel phosphate binder that is based ...
(Date:2/25/2015)... (PRWEB) February 25, 2015 Market Publishers ... studies drawn up by 9Dimen Research have been recently ... Mortar Industry 2014 Market Research Report . This research ... the performance of the world adhesive mortar industry as ... situation across the major regional markets. It focuses on ...
Breaking Biology Technology:Dyadic International To Announce Fourth Quarter 2014 Financial Results And Host Conference Call On Wednesday, March 11, 2015 2Dyadic International To Announce Fourth Quarter 2014 Financial Results And Host Conference Call On Wednesday, March 11, 2015 3Lexicon To Present At The Cowen 35th Annual Health Care Conference 2Phosphate Therapeutics Announces Completion of Subject Recruitment Into the PEACH Pivotal Phase 2 Study of its Novel Phosphate Binder (PT20) for the Treatment of Hyperphosphataemia 2Phosphate Therapeutics Announces Completion of Subject Recruitment Into the PEACH Pivotal Phase 2 Study of its Novel Phosphate Binder (PT20) for the Treatment of Hyperphosphataemia 3New Research Studies by 9Dimen Research Now Available at MarketPublishers.com 2New Research Studies by 9Dimen Research Now Available at MarketPublishers.com 3New Research Studies by 9Dimen Research Now Available at MarketPublishers.com 4
... researchers have found that the body,s innate ability to ... more effective and less costly artificial respirators. The new ... or paralysis currently necessary for some patients on mechanical ... adapt to recurring stimuli, is the focus of work ...
... Rice University chemists have discovered a way to load ... gold spheres. The result is a tiny ball, many times ... drug. , Paclitaxel, which is sold under the brand name ... works. , "Paclitaxel is one of the most effective anti-cancer ...
... new approach to discover life on Mars were successfully ... low-Earth orbit experiment to assess their survivability in the ... The new approach is based on technology similar to ... are embodied in the Life Marker Chip (LMC) experiment, ...
Cached Biology Technology:MIT: Leveraging learning for artificial respiration 2Taxol bristle ball: a wrench in the works for cancer 2Life on Mars 'pregnancy test' successfully launched 2
(Date:1/22/2015)... TORONTO , Jan. 13, 2015 /PRNewswire/ - Today, FindBiometrics, the ... announced the launch of its new website design. ... in its infancy", says Peter O,Neill , founder and ... ever, the industry needs involvement from the key players on ...
(Date:1/22/2015)... DETROIT , Jan. 13, 2015 Technology Showcase, Hall ... iris-based identity authentication solutions, today announced it will showcase its ... and developed by the Department of Energy,s Oak Ridge ... International Auto Show . EyeLock,s iris identity authentication technology is ...
(Date:1/22/2015)... N.C. , Jan. 16, 2015  A man-made form ... memory and other mental capabilities in adults with mild ... pilot study led by researchers at Wake Forest Baptist ... adults diagnosed with amnesic mild cognitive impairment (MCI) or ...
Breaking Biology News(10 mins):Identity Industry Leading Publication Debuts New Look As Biometrics Hit Mainstream 2EyeLock Debuts First Iris Authentication Technology Embedded in 3D Printed Automobile 2EyeLock Debuts First Iris Authentication Technology Embedded in 3D Printed Automobile 3Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 3
... has revealed that the extremely hot, dry and windy conditions ... ,horizontal convective rolls, -similar to streamers of wind flowing through ... study is the first of its kind to produce such ... provides insights for future fire management and warning systems. ...
... looking for information on the evolution and function ... Ravosa is your man. His integrative research ... the mammalian musculoskeletal system during development and across ... increasingly central role of the chewing complex in ...
... international research collaboration recently demonstrated progress in protecting cassava ... disease, in a confined field trial in Uganda using ... planted in November 2010 following approval by the National ... in November 2011 and results were published in the ...
Cached Biology News:Unusual weather events identified during the Black Saturday bushfires 2Notre Dame researcher is shedding light on how jaws evolve 2Researchers demonstrate control of devastating cassava virus in Africa 2
...
...
... Mouse polyclonal antibody raised against ... Immunogen: K6HF ... a.a) partial recombinant protein with ... Accession Number: NM_004693 ...
... role in the regulation of signaling pathways ... variants have been reported that affect both ... pathways. With Apoptosis and Cell Death ... profiling and at the same time detect ...
Biology Products: